Quick Dispatch:
Your soul trial oral semaglutide cardiovascular outcomes 2025 results Trial Scorecard: SOUL orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your soul trial oral semaglutide cardiovascular outcomes 2025 results Trial Scorecard: SOUL ships.
Need Help?
Questions about soul trial oral semaglutide cardiovascular outcomes 2025 results Trial Scorecard: SOUL, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for soul trial oral semaglutide cardiovascular outcomes 2025 results Trial Scorecard: SOUL in your area.
Oral semaglutide found to lower risk of heart failure events in people with type 2 diabetes
24.24
SOUL (Semaglutide cardiOvascular oUtcomes triaL) in individuals with
28.24
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
20.94
Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial
29.15
Oral Semaglutide in High-Risk Type 2 Diabetes: Cardiovascular Benefit Confirmed in the SOUL Trial
29.34
Oral Semaglutide Reduces Cardiovascular Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized Trial
28.98
Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial
27.89
